Lee's Pharmaceutical Holdings Limited
LPCUF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $347,411 | $347,411 | $370,812 | – |
| % Growth | 0% | -6.3% | – | – |
| Cost of Goods Sold | $167,384 | $167,384 | $169,432 | – |
| Gross Profit | $180,027 | $180,027 | $201,380 | – |
| % Margin | 51.8% | 51.8% | 54.3% | – |
| R&D Expenses | $20,806 | $20,806 | $49,091 | – |
| G&A Expenses | $50,800 | $50,800 | $49,122 | – |
| SG&A Expenses | $127,326 | $127,326 | $163,388 | – |
| Sales & Mktg Exp. | $76,290 | $76,290 | $107,514 | – |
| Other Operating Expenses | -$1,862 | -$1,862 | -$33,602 | – |
| Operating Expenses | $146,269 | $146,269 | $178,876 | – |
| Operating Income | $33,758 | $33,758 | $22,504 | – |
| % Margin | 9.7% | 9.7% | 6.1% | – |
| Other Income/Exp. Net | -$3,420 | -$3,420 | -$4,002 | – |
| Pre-Tax Income | $30,338 | $30,338 | $18,503 | – |
| Tax Expense | $5,065 | $5,065 | $11,631 | – |
| Net Income | $33,593 | $33,593 | $15,311 | – |
| % Margin | 9.7% | 9.7% | 4.1% | – |
| EPS | 0.057 | 0.057 | 0.026 | – |
| % Growth | 0% | 119.2% | – | – |
| EPS Diluted | 0.057 | 0.057 | 0.026 | – |
| Weighted Avg Shares Out | 588,836 | 588,836 | 588,865 | – |
| Weighted Avg Shares Out Dil | 588,841 | 588,841 | 588,835 | – |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | – |
| Interest Expense | $0 | $0 | $0 | – |
| Depreciation & Amortization | $36,075 | $36,075 | $8,128 | – |
| EBITDA | $69,266 | $69,266 | $41,377 | – |
| % Margin | 19.9% | 19.9% | 11.2% | – |